Investigations on the Spectral Interactions of Fusarin C with Rat Liver Microsomal Cytochrome P-450

References

• Ames B. N., Durston W. E., Yamasaki E., Lee F. D. Carcinogens are mutagens: a simple test system combining liver homogenates for activation and bacteria detection. Proceedings of the National Academy of Science 1973; 70: 2281–2285
   PubMed Web of Science ®Google Scholar
• Backes W. L., Jansson I., Mole J. E., Gibson G. G., Schenkman J. B. Isolation and comparison of four cytochrome P‐450 isozymes from phenobarbital‐induced rat liver: three forms possessing identical NH2‐terminal sequences. Pharmacology 1985; 31: 155–169
   PubMed Web of Science ®Google Scholar
• Cheng S. J., Tiang Y. Z., Li M. H., Lo H. Z. A mutagenic metabolite produced by Fusarium moniliforme isolates from Linxian county, China. Carcinogenesis 1985; 6: 903–905
   PubMed Web of Science ®Google Scholar
• Gelderblom W. C. A., Thiel P. G., Van DER Merwe K. J. The role of rat liver microsomal enzymes in the metabolism of the fungal metabolite, fusarin C. Food and Chemical Toxicology 1988a; 26: 31–36
   PubMed Web of Science ®Google Scholar
• Gelderblom W. C. A., Thiel P. G., Van DER Merwe K. J. The chemical and enzymatic interaction of glutathione with the fungal metabolite, fusarin C. Mutation Research 1988b; 199: 207–214
   PubMedGoogle Scholar
• Gelderblom W. C. A., Thiel P. G., Jaskiewicz K., Marasas W. F. O. Investigations on the carcinogenicity of fusarin C—a mutagenic metabolite of Fusarium moniliforme. Carcinogenesis 1986; 7: 1899–1901
   PubMed Web of Science ®Google Scholar
• Gelderblom W. C. A., Thiel P. G., Van DER Merwe K. J. Metabolic activation and deactivation of fusarin C, a mutagen produced by Fusarium moniliforme. Biochemical Pharmacology 1984a; 33: 1601–1603
   PubMed Web of Science ®Google Scholar
• Gelderblom W. C. A., Thiel P. G., Marasas W. F. O., Van DER Merwe K. J. Natural occurrence of fusarin C, a mutagen produced by Fusarium moniliforme in corn. Journal of Agricultural and Food Chemistry 1984b; 32: 1064–1067
   Web of Science ®Google Scholar
• Gelderblom W. C. A., Thiel P. G., Van DER Merwe K. J., Marasas W. F. O., Spies H. S. C. A mutagen produced by Fusarium moniliforme. Toxicon 1983; 21: 467–473
   PubMed Web of Science ®Google Scholar
• Guarino A. M., Gram T. E., Gigon P. L., Greene F. E., Gillette J. R. Changes in Michaelis and spectral constants for aniline in hepatic microsomes from phenobarbital‐treated rats. Molecular Pharmacology 1968; 5: 131–136
   Web of Science ®Google Scholar
• Junge W., Krisch K. The carboxylesterases/amidases of mammalian liver and their possible significance. CRC Critical Reviews in Toxicology 1975; 3: 371–434
   PubMedGoogle Scholar
• Kriek N. P. J., Marasas W. F. O., Thiel P. G. Hepato‐ and cardiotoxicity of Fusarium verticillioides (F. moniliforme) isolates from southern Africa maize. Foods and Chemical Toxicology 1981; 19: 447–456
   Google Scholar
• Leibman K. C., Hildebrandt A. G., Estabrook R. W. Spectrophotometric studies of interactions between various substrates in their binding to microsomal cytochrome P‐450. Biochemical and Biophysical Research Communications 1969; 36: 789–794
   PubMed Web of Science ®Google Scholar
• Lowry O. H., Rosebrough W. J., Farr A. L., Randall R. J. Protein measurements with the folin phenol reagent. Journal of Biological Chemistry 1951; 193: 265–275
   PubMed Web of Science ®Google Scholar
• Marasas W. F. O., Kriek N. P. J., Fincham J. E., Van Rensburg S. J. Primary liver cancer and oesophageal basal cell hyperplasia in rats caused by Fusarium moniliforme. International Journal of Cancer 1984; 34: 383–387
   PubMed Web of Science ®Google Scholar
• Omura T., Sato R. The carbon monoxide binding pigement of liver microsomes. II. Solubilization, purification and properties. Journal of Biological Chemistry 1964; 239: 2379–2385
   PubMed Web of Science ®Google Scholar
• Orrenius S., Kupfer D., Ernster L. Substrate binding to cytochrome P‐450 of liver and adrenal microsomes. FEBS Letters 1970; 6: 249–252
   PubMed Web of Science ®Google Scholar
• Politzer P., Trefonas P. An analysis of the reactivities of epoxide rings in some cyclic hydrocarbons. Carcinogenesis: Fundamental Mechanisms and Environmental Effects, B. Pullman, P. O. P. Ts'O, H. Gelbion. Reidel Publishers, Boston 1980; 67–79
   Google Scholar
• Ryan E. D., Thomas P. E., Korzeniowski D., Levin W. Separation and characterization of highly purified forms of liver microsomal cytochrome P‐450 from rats treated with polychlorinated biphenyls, phenobarbital, and 3‐methylcholanthrene. Journal of Biological Chemistry 1979; 254: 1365–1374
   PubMed Web of Science ®Google Scholar
• Schenkman J. B. Studies on the nature of the type I and type II spectral changes in liver microsomes. Biochemistry 1970; 9: 2081–2091
   PubMed Web of Science ®Google Scholar
• Schenkman J. B., Cinti D. L., Orrenius S., Moldues P., Kraschnitz R. The nature of the reverse type I (modified type II) spectral changes in liver microsomes. Biochemistry 1972; 11: 4243–4251
   PubMed Web of Science ®Google Scholar
• Schenkman J. B., Remmer H., Estabrook R. W. Spectral studies of drug interaction with hepatic microsomal cytochrome. Molecular Pharmacology 1967; 3: 113–123
   PubMed Web of Science ®Google Scholar
• Van DEN Berg A. P., Noordhoek J., Koopman‐Kool E. The relation between the secdependency of type I binding of ethylmorphine and the 1‐butanol‐induced spectral change in mouse liver microsomes. Biochemical Pharmacology 1979a; 28: 31–36
   PubMed Web of Science ®Google Scholar
• Van DEN Berg A. P., Noordhoek J., Koopman‐Kool E. The use of competitive inhibition of substrate‐binding to cytochrome P‐450 in the determination of spectral dissociation constants for substrates with multiple types of binding, as illustrated with 1‐butanol. Biochemical Pharmacology 1979b; 28: 37–41
   PubMed Web of Science ®Google Scholar